Tag

Esc Congress

All articles tagged with #esc congress

Xylitol Linked to Higher Heart Risk in New Observational Study
health1 month ago

Xylitol Linked to Higher Heart Risk in New Observational Study

A new observational study presented at the 2026 European Society of Cardiology (ESC) Congress found that higher blood levels of xylitol, a common sugar substitute, are associated with an increased risk of major cardiovascular events. The research, led by Dr. Marco Witkowski of Charité University Hospital in Berlin, analyzed data from over 17,700 participants in Canada and the UK. Findings indicate a 57% higher risk of heart attack, stroke, or death over six years for those with the highest xylitol levels, and an 18% higher risk over 30 years. While the study does not prove causation, it suggests a dose-dependent relationship. Experts emphasize that more research is needed, particularly as xylitol use in products grows. Meanwhile, health professionals recommend focusing on overall heart-healthy diets rather than solely swapping sweeteners.

Xylitol Linked to Higher Heart Risk in Large Observational Study
health1 month ago

Xylitol Linked to Higher Heart Risk in Large Observational Study

A large observational study presented at the European Society of Cardiology (ESC) Congress in Munich found that high blood levels of xylitol, a common artificial sweetener, are associated with a significantly increased risk of major adverse cardiovascular events, including heart attack, stroke, and death. The study, which analyzed data from 17,710 participants across two cohorts, showed a 57% higher risk over six years and an 18% higher risk over 30 years for those with the highest xylitol levels compared to those with the lowest. The findings suggest a dose-dependent relationship, meaning higher exposure correlates with greater risk, even after adjusting for factors like age, sex, and existing health conditions. While the study does not prove causation, it highlights the need for further research into the long-term safety of xylitol, which is widely used in foods, beverages, and oral care products.

Xylitol linked to higher cardiovascular risk in large observational study
health1 month ago

Xylitol linked to higher cardiovascular risk in large observational study

A large observational study presented at the European Society of Cardiology Congress found that higher blood levels of xylitol, a common artificial sweetener, are associated with an increased risk of major adverse cardiovascular events. The analysis of 17,710 participants showed a 57% higher risk over six years and an 18% higher risk over 30 years for those with the highest xylitol levels, even after adjusting for standard risk factors. Researchers emphasize that while the association is dose-dependent, the observational nature of the study does not prove causation, and further research is needed as xylitol usage in consumer products continues to rise.

Xylitol Consumption Linked to Elevated Cardiovascular Risk in Large Study
health1 month ago

Xylitol Consumption Linked to Elevated Cardiovascular Risk in Large Study

A large observational study presented at the European Society of Cardiology (ESC) Congress in Munich found that high blood levels of xylitol, a common artificial sweetener, are associated with a significantly increased risk of major adverse cardiovascular events, including heart attack, stroke, and death. The research, led by Dr. Marco Witkowski of Charité University Hospital in Berlin, analyzed data from 17,710 participants across two cohorts. Over a six-year period, individuals with the highest xylitol levels faced a 57% higher risk compared to those with the lowest levels, while an 18% higher risk persisted over a 30-year follow-up. The findings suggest a dose-dependent relationship, meaning risk increases with higher exposure. Although the study is observational and does not prove causation, experts emphasize the need for further research as xylitol usage in foods and oral care products continues to rise.

Xylitol Linked to 57% Higher Heart Risk in Large Observational Study
health1 month ago

Xylitol Linked to 57% Higher Heart Risk in Large Observational Study

A large observational study presented at the European Society of Cardiology Congress in Munich found that higher blood levels of xylitol, a common artificial sweetener, are associated with a significantly increased risk of major adverse cardiovascular events, including heart attack, stroke, and death. The research, which analyzed data from over 17,700 participants in Canadian and British cohorts, indicates a dose-dependent relationship where higher xylitol concentrations correlate with higher cardiovascular event rates. While the findings are not causal, they raise concerns about the long-term safety of a sweetener widely regarded as safe by regulatory agencies and consumed by millions as a sugar alternative.

Xylitol Linked to 57% Higher Heart Risk in Large European Study
health1 month ago

Xylitol Linked to 57% Higher Heart Risk in Large European Study

A large observational study presented at the European Society of Cardiology (ESC) Congress in Munich found that high blood levels of xylitol, a common artificial sweetener, are associated with a significantly increased risk of major adverse cardiovascular events (MACE), including heart attack, stroke, and death. The research, led by Dr. Marco Witkowski of Charité University Hospital in Berlin, analyzed data from over 17,700 participants across two cohorts: the Canadian Longitudinal Study on Aging and the European Prospective Investigation into Cancer (EPIC)-Norfolk. Over a six-year period, individuals with the highest xylitol levels faced a 57% higher risk of MACE compared to those with the lowest levels. In the longer-term EPIC-Norfolk cohort, the risk remained 18% higher after 30 years. The association appeared dose-dependent and persisted even after adjusting for factors such as age, sex, body mass index, hypertension, diabetes, and lipid levels. While the study does not prove causation, it highlights potential cardiovascular risks associated with xylitol, which is widely used in sugar-free gum, dental products, and foods. Researchers emphasize the need for further studies, especially as xylitol usage in consumer products continues to rise.

Major Trial Finds AF Ablation No Better Than Placebo for Quality of Life
health1 month ago

Major Trial Finds AF Ablation No Better Than Placebo for Quality of Life

The PVI-SHAM-AF trial, presented at the 2026 European Society of Cardiology Congress, found that catheter ablation for atrial fibrillation (AF) did not significantly improve quality of life compared to a sham procedure. While ablation reduced AF episodes and burden, the placebo group showed similar improvements in quality of life scores, challenging the long-held belief that ablation directly drives patient well-being.